Michael Zdenek David, M.D., Ph.D.
USA

Michael Zdenek David, M.D., Ph.D.

Effective control of MRSA

Biography

Academic Appointments 2009-2011 Instructor, Departments of Medicine, Pediatrics, and Public Health Sciences, University of Chicago (UChicago), Chicago, Illinois, USA. 2012-2017 Assistant Professor, Departments of Medicine, Pediatrics, and Public Health Sciences, UChicago. 2017-2024 Assistant Professor, Departments of Medicine and Biostatistics, Epidemiology and Informatics, University of Pennsylvania (UPenn), Philadelphia, Pennsylvania. 2017- Senior Scholar, Center for Clinical Epidemiology and Biostatistics, UPenn. 2023- Associate Professor, Departments of Medicine, and Biostatistics, Epidemiology & Informatics, UPenn. 2024- Co-Director, Public Health Certificate Program, UPenn.

Education and Training 1993-2001 Yale University School of Medicine, New Haven, Connecticut. M.D. 1995-2007 UChicago, Department of History, Chicago, Illinois. Ph.D., Russian history. 2001-2004 Yale-New Haven Hospital, New Haven, Connecticut. Residency, Internal Medicine. 2004-2007 UChicago, Health Studies, M.S. Epidemiology and biostatistics. 2006-2009 UChicago, Department of Medicine, Infectious Diseases Clinical Fellow.

Society Office 2014- Member, International Society of Antimicrobial Chemotherapy (ISAC); Member, Executive Committee (10/2024-); MRSA Working Group, Secretary (4/2019-).

Editorial Board Membership 2014- Epidemiology and Infection 2020- Editorial Advisory Board (EAB) Member, Clinical Infectious Diseases

Participation on Grant Review Panel 2023- Member, NIAID, National Institutes of Health, Etiology, Diagnostic, Intervention and Treatment of Infectious Diseases Study Section (EDIT), Infectious Diseases and Immunology B Integrated Review Group (IDIB), Bethesda, Maryland.

Recent Publications (total number: 120; see https://orcid.org/0000-0002-1926-7800) 1. Raghuram V, Jessica J. Gunoskey JJ, Katrina S. Hofstetter KS, Jacko NF, Margot J. Shumaker MJ, Hu YJ, Read TD, David MZ. Comparison of genomic diversity between single and pooled Staphylococcus aureus colonies isolated from human colonisation cultures. Microbial Genomics, 2023 Nov;9(11):001111. 2. Talbot B, Jacko N, Hofstetter K, Alahakoon T, Bouiller K, Read TD, David MZ. Genomic investigation of MRSA bacteremia relapse reveals diverse genomic profiles but convergence in bacteremia-associated genes. Journal of Infectious Diseases, 2025 Jul 25:jiaf352. 3. Bouiller K, Jacko NF, Hiehle M, Cella E, Azarian T, David MZ. Epidemiological and genetic definitions of relapse in patients with MRSA bone and joint infection. Clinical Infectious Diseases, 2025 Aug 11:ciaf448. doi: 10.1093/cid/ciaf448.

Recent Grants 2018-2023 Principal Investigator. NIH 1R01AI139188-01 (NIAID). “Genomics of S. aureus colonization after initial and recurrent skin infections and the impact of antibiotics.” (8/16/18-7/31/23; no cost extension through 7/31/25). 2022-2027 Principal Investigator. NIH 1 R01 AI158452-01A1 (NIAID). “Staphylococcus aureus SPREAD (S. aureus Study of Prevalence Resistance and Environmental Dissemination).” (7/1/22-6/30/27).